Key result
CT pulmonary angiography and PET-CT imaging revealed characteristic features of pulmonary artery sarcoma, including extraluminal extension and high metabolic activity, leading to the correct diagnosis.
Why the study?
Pulmonary artery sarcoma is extremely rare and often misdiagnosed as pulmonary thromboembolism due to similar clinical and imaging features, requiring multimodality imaging and recognition of specific characteristics for correct diagnosis.
Case Report (n=1)
No
Multimodality imaging is crucial for differentiating rare pulmonary artery sarcoma from pulmonary thromboembolism.
Answers are grounded in this paper and cite their sources.
Supports multimodality imaging to differentiate pulmonary artery sarcoma from thromboembolism; leaves open prospective validation in larger cohorts.
Pulmonary artery (PA) sarcoma is an extremely rare malignant tumor of pulmonary artery. It is often misdiagnosed as pulmonary thromboembolism (PTE) because of its clinical and imaging features which are quite similar to PTE. Multimodality diagnostic imaging and recognition of specific imaging characteristics with appropriate clinical suspicion are required to make correct diagnosis. In this report, we present a case of PA sarcoma with imaging and clinical features as well as emphasize significance of using multimodality imaging.
No takes yet. Share an insight, caveat, or question.
Yazgan et al. (2020) conducted a case report in Pulmonary artery sarcoma (n=1). Multimodality imaging (CTPA and PET-CT) was evaluated on Diagnosis of pulmonary artery sarcoma. CT pulmonary angiography and PET-CT imaging revealed characteristic features of pulmonary artery sarcoma, including extraluminal extension and high metabolic activity, leading to the correct diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: